Page last updated: 2024-11-04

rolipram and Ureteral Obstruction

rolipram has been researched along with Ureteral Obstruction in 1 studies

Ureteral Obstruction: Blockage in any part of the URETER causing obstruction of urine flow from the kidney to the URINARY BLADDER. The obstruction may be congenital, acquired, unilateral, bilateral, complete, partial, acute, or chronic. Depending on the degree and duration of the obstruction, clinical features vary greatly such as HYDRONEPHROSIS and obstructive nephropathy.

Research Excerpts

ExcerptRelevanceReference
"Renal interstitial inflammation is a consequence of unilateral ureteral obstruction (UUO)."1.33A2A adenosine receptor agonist and PDE4 inhibition delays inflammation but fails to reduce injury in experimental obstructive nephropathy. ( Chevalier, RL; Forbes, MS; Lange-Sperandio, B; Linden, J; Okusa, MD; Thornhill, B, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lange-Sperandio, B1
Forbes, MS1
Thornhill, B1
Okusa, MD1
Linden, J1
Chevalier, RL1

Other Studies

1 other study available for rolipram and Ureteral Obstruction

ArticleYear
A2A adenosine receptor agonist and PDE4 inhibition delays inflammation but fails to reduce injury in experimental obstructive nephropathy.
    Nephron. Experimental nephrology, 2005, Volume: 100, Issue:3

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Apoptosis; Cell Proliferation; Cyclic Nucleotide Phosp

2005